Gerhard W. Sennewald, Ph.D.,, has served as a director of BSD since 1994. From April 1985 to the present, Dr. Sennewald has served as the President and Chief Executive Officer of Dr. Sennewald Medizintechnik GmbH, of Munich, Germany, a firm which is engaged in the business of distributing hyperthermia equipment and diagnostic imaging equipment and services. In connection with his service to Dr. Sennewald Medizintechnik GmbH, Dr.

Douglas P. Boyd, Ph.D., has served as a director of BSD since 2005. From January 2007 to the present, Dr. Boyd has served as Chief Executive Officer of TeleSecurity Sciences, Inc., a privately-held company in the business of developing solutions for increasing the effectiveness and automation of airport explosives detection systems. From 1983 to 2005, Dr. Boyd was an adjunct professor of radiology at the University of California, San Francisco. From 1980 to 2004

Harold R. Wolcott has served as a director of BSD since April 2009.  Mr. Wolcott also has served as President of BSD since April 2009.  Mr. Wolcott has 43 years experience managing and growing newly-formed venture capital financed corporations as well as multi-million dollar medical device businesses with international operations.

Dixie Toolson Sells (VP Regulatory Affairs) joined BSD Medical in 1978 and has directed the Company’s regulatory affairs since 1984. During her tenure at BSD, Ms. Sells has been instrumental in obtaining fifty-one approvals from the FDA, including thirteen Pre-marketing (PMA) approvals, (both original PMA approvals and supplemental approvals for significant product changes), two 510(k) approvals, and twenty-six Investigational Device Exemption (IDE)